---
title: "Equilibrium Inc."
author: "Akshay Gulabrao"
date : "2025 October 23"
bibliography: library.bib
link-citations: true
---
[Home](./index.html)

Equilibrium Inc. currently trades at $1.32 as of 2025/10/23. There main drug is EQ504.

# Overview

Aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor. Activation of AHR is a necessary signaling pahtway for help. TCDD(a toxin) is a harmful continuous signal that disrupts normal cellular functions and causes toxicity. Dietary ligands (from foods) are short-lived, natural compounds. They provide  [@chenModulatingAHRFunction2023].

# References